Bioequivalence Studies

QR Code

Bioequivalence Studies

None

Saved in:

Bibliographic Details
Main Author:	Qayyum, Aisha
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/35666
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Computer Simulations as a Tool for Optimizing Bioequivalence Trials
by: Navarro-Fontestad, Carmen, et al.
Published: (2012)

Biowaiver as a Bioequivalence Study Option
by: E. A. Volkova, et al.
Published: (2024-02-01)

Bioequivalence study drug containing memantine
by: A. A. Karlitskaya, et al.
Published: (2013-09-01)

Pharmacokinetics and Safety with Bioequivalence of Isosorbide Mononitrate Sustained-Release Tablets in Chinese Healthy Volunteers: Bioequivalence Study
by: Wu B, et al.
Published: (2025-07-01)

BIOEQUIVALENCE STUDY OF GENERIC MOLNUPIRAVIR IN HEALTHY VOLUNTEERS
by: V. B. Vasilyuk, et al.
Published: (2023-02-01)

Bioequivalence study of generic nirmatrelvir in healthy volunteers
by: R. A. Oseshnyuk, et al.
Published: (2023-05-01)

Planning and Evaluation of Bioequivalence Studies of Enalapril Products
by: D. P. Romodanovsk, et al.
Published: (2018-12-01)

PLANNING AND EVALUATION OF BIOEQUIVALENCE STUDIES OF ATAZANAVIR PRODUCTS
by: N. E. Uvarova, et al.
Published: (2018-12-01)

Bioequivalence study of ondansetron tablets by HPLC-MS
by: E. S. Stepanova, et al.
Published: (2014-04-01)

Evaluation of Bioequivalence of Generic Imatinib Products and Generic Tacrolimus Products Based on Indirect Comparison of the Results of Their Bioequivalence Studies
by: D. V. Goryachev, et al.
Published: (2019-09-01)

Highly variable medicines - specific aspects of bioequivalence studies
by: D. P. Romodanovsky, et al.
Published: (2018-02-01)

Planning Bioequivalence Studies in the Context of the COVID-19 Pandemic
by: D. P. Romodanovsky, et al.
Published: (2021-03-01)

Planning and evaluation of bioequivalence studies of rosuvastatin drug products
by: D. P. Romodanovsky, et al.
Published: (2018-02-01)

Problems of bioanalytical part of bioequivalence studies of drugs in Russia
by: A. L. Khokhlov, et al.
Published: (2014-04-01)

Proteasome Targeted Therapies in Rheumatoid Arthritis
by: Ahmed, Aisha Siddiqah
Published: (2012)

Planning and Evaluation of Bioequivalence Studies of Telmisartan Generic Drug Products
by: A. L. Khokhlov, et al.
Published: (2019-09-01)

Specific features of the bioequivalence study of drugs - analogs of endogenous compounds
by: V. K. Adonin, et al.
Published: (2018-02-01)

Expert Approaches to the Assessment of Losartan Drugs Bioequivalence
by: D. P. Romodanovsky, et al.
Published: (2020-02-01)

Alternative and Traditional Medicines Systems in Pakistan: History, Regulation, Trends, Usefulness, Challenges, Prospects and Limitations
by: Hussain, Shahzad, et al.
Published: (2012)

Comparative Bioequivalence Studies of doxysam and doxycycline (Pfizer) by reversed phase HPLC.
by: Baghdad Science Journal
Published: (2010-03-01)

Bioequivalency study as a method for confirming identity in original medications and generics
by: S. Yu. Martsevich, et al.
Published: (2005-04-01)

Bioequivalence study of tablet forms of risperidone, olanzapine and quetiapine in healthy volunteers
by: V. V. Pisarev, et al.
Published: (2013-04-01)

Modern approaches to the assessment of orally inhaled products bioequivalence
by: E. S. Petrova, et al.
Published: (2018-02-01)

Relevant Issues of Planning Bioequivalence Studies of Drugs with a Narrow Therapeutic Range
by: D. P. Romodanovsky
Published: (2020-09-01)

PRT to predict pharmacokinetic profiles as part of a bioequivalence study of the drug deferasirox
by: A. V. Suvorova, et al.
Published: (2024-09-01)

Single-Dose Bioequivalence Study of Rivaroxaban-Containing Medicinal Products in Healthy Volunteers
by: G. N. Gildeeva, et al.
Published: (2022-10-01)

Study of the pharmacokinetic profile of the medicinal product Gidazepam®, tablets, 50 mg in a bioequivalence study
by: E. V. Baskakov, et al.
Published: (2023-11-01)

Formulation and Bioequivalence Evaluation of a Miniaturized Fexofenadine Hydrochloride Tablet
by: Woo-Yul Song, et al.
Published: (2025-06-01)

Optimisation of Approaches to Adverse Event Analysis in Bioequivalence Clinical Trials
by: A. B. Verveda, et al.
Published: (2024-04-01)

Evaluation of bioequivalence of two tablet forms of lisinopril in healthy volunteers
by: S. A. Altynbekov, et al.
Published: (2013-09-01)

PRINCIPLES OF STATISTICAL EVALUATION OF BIOEQUIVALENCE STUDIES IN THE CONTEXT OF CURRENT REGULATORY REQUIREMENTS AND LEGAL ACTS
by: D. P. Romodanovsky, et al.
Published: (2018-06-01)

Pharmacokinetic and bioequivalence study of Telzap® in comparison with Mikardis® in healthy subjects after single administrationl
by: A. L. Khokhlov, et al.
Published: (2023-01-01)

Effects of Food on the Bioavailability of Medicinal Products in Bioequivalence Studies: A Comparative Analysis of Regulatory Documents
by: N. N. Eremenko
Published: (2025-04-01)

INFLUENCE OF SEX DIFFERENCES ON PHARMACOKINETICS OF DRUGS WITHIN THE FRAMEWORK OF BIOEQUIVALENCE STUDIES OF GENERIC MEDICINAL PRODUCTS
by: D. P. Romodanovsky, et al.
Published: (2018-09-01)

MOTIVATION AND PARTICIPATION EXPERIENCE OF HEALTHY VOLUNTEERS IN THE CLINICAL TRIALS OF BIOEQUIVALENCE IN RUSSIA
by: I. V. Mareev, et al.
Published: (2019-01-01)

Analysis of the features of planning bioequivalence studies with adaptive design for drug products analogous to endogenous compounds ademetionine
by: N. N. Eremenko
Published: (2025-06-01)

Comparative analysis of physicochemical properties, bioequivalence, safety and tolerability of the first domestic semaglutide
by: A. S. Ametov, et al.
Published: (2024-01-01)

Bioequivalence of bisoprolol, coated tablets 10 mg JSC «Chimpharm» Republic of Kazakhstan
by: Y. M. Budach, et al.
Published: (2013-04-01)

Artificial Intelligence Meets Bioequivalence: Using Generative Adversarial Networks for Smarter, Smaller Trials
by: Anastasios Nikolopoulos, et al.
Published: (2025-05-01)

Regulatory requirements of the European Medicines Agency for evaluation of bioequivalence of modified-release medicinal products
by: D. P. Romodanovsky, et al.
Published: (2019-03-01)